Both in Biotechnology
Pelthos Therapeutics vs Aligos Therapeutics
Over the past year PTHS returned −74.9% and ALGS returned −38.5%; their daily moves had a correlation of 0.13.
PTHS −74.9% ALGS −38.5%Growth of $1, one year, split-adjusted
| Metric | PTHS | ALGS |
|---|---|---|
| Price | $9.30 | $4.51 |
| Market cap | $36.6M | $28.2M |
| Today | −8.37% | −10.16% |
| 1 month | −55.7% | −15.2% |
| 6 months | −62.8% | −25.2% |
| Year to date | −70.0% | −51.6% |
| 1 year | — | −37.4% |
| Revenue growth (YoY) | — | +2778.5% |
| Gross margin | 76.9% | 100.0% |
| Net margin | −150.1% | −5.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.8× | 0.9× |
| Net cash | -$45.7M | $30.3M |
| Dividend yield | — | — |
| Volatility (60d) | 141.3% | 68.5% |
| Short % of float | 8.6% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).